Physician profile
Tamera N Thoener
NPI 1194198218
$254,327.65
in general payments reported to CMS, 2019-2025
28 companies · $105K in 2025
The $105K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,444 · 2022: $5,680 · 2023: $39K · 2024: $97K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $156K · Travel and Lodging: $76K · Food and Beverage: $9,621 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $155,763.75 |
| Travel and Lodging | $75,664.92 |
| Food and Beverage | $9,620.84 |
| Education | $154.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $223,069.12 | 2021-2025 | Otezla, Otezla, Repatha |
| Abbvie INC. | $21,686.73 | 2021-2025 | |
| Merz North America, INC. | $3,658.96 | 2023-2025 | Xeomin |
| Allergan, INC. | $1,628.47 | 2021 | |
| Janssen Biotech, INC. | $929.12 | 2024-2025 | Tremfya |
| Bayer Healthcare Pharmaceuticals INC. | $561.25 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $489.86 | 2021 | |
| Novo Nordisk INC | $447.38 | 2021-2025 | Wegovy |
| Lilly USA, LLC | $354.92 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $276.91 | 2021-2025 | Saphnelo, Breztri, Airsupra |
| Merz Pharmaceuticals, LLC | $143.47 | 2023 | Xeomin |
| Axsome Therapeutics, INC. | $138.29 | 2025 | Auvelity, Symbravo |
| Teva Pharmaceuticals USA, INC. | $135.91 | 2024 | Austedo Xr |
| Esperion Therapeutics, INC. | $125.00 | 2022 | |
| Akcea Therapeutics, INC. | $116.50 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $113.68 | 2022 | |
| Exact Sciences Corporation | $106.48 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $66.31 | 2023-2024 | Vyepti |
| Ibsa Pharma INC. | $47.83 | 2025 | Tirosint, Flector, Licart |
| Takeda Pharmaceuticals U.S.A., INC. | $40.70 | 2025 | Trintellix |
| Pfizer INC. | $39.79 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $32.16 | 2022-2023 | Quviviq |
| Janssen Scientific Affairs, LLC | $26.34 | 2025 | Tremfya |
| Medtronic, INC. | $22.83 | 2023 | Minimed 780g |
| Ucb, INC. | $22.02 | 2024 | Bimzelx |
| Astellas Pharma US INC | $21.05 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $13.40 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamera Thoener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.